Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 65 or older who receive care from a local community health service centre.
- People who have been diagnosed with type 2 diabetes, confirmed by at least one of the following: typical diabetes symptoms with a high random blood sugar reading; a fasting blood sugar level of 7.0 mmol/L or higher (after no food or drink for 8 hours); a blood sugar level of 11.1 mmol/L or higher two hours after a glucose drink test; or current or past use of diabetes medication. (Each blood sugar result must be confirmed with a repeat test.)
- People who also have chronic kidney disease and/or a high or very high risk of heart or blood vessel disease, meeting at least one of the following conditions: a history of heart disease, stroke, or poor circulation in the legs or feet; signs of organ damage such as protein in the urine, reduced kidney function (but not below a certain level), an enlarged heart muscle, or eye disease related to diabetes; three or more major risk factors including age 65 or older, high blood pressure, abnormal cholesterol levels, smoking, or obesity; or a diabetes duration of 10 or more years plus at least one heart disease risk factor such as older age, obesity, smoking, an inactive lifestyle, a family history of heart disease, high blood pressure, or abnormal cholesterol levels.
Who may not be able to join:
- Women who are pregnant or planning to become pregnant.
- People whose kidney function is below a certain level, specifically an eGFR lower than 30 mL/min/1.73m² as measured by the CKD-EPI formula (confirm with trial site).
- People who are unlikely to be able to attend follow-up appointments for the full 36 months of the trial, due to health reasons or plans to move away.
- People who are unwilling or unable to sign a consent form agreeing to take part.
- People who have type 1 diabetes.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiaoying Li, MD, Fudan University
Phone: 13651913857
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary Outcome of Phase 1: Comprehensive management effect of various cardiovascular risk factors in T2D，meeting control targets for a combination of A1c, BP, LDL-C.; Primary Outcome of Phase 2: Composite of 3P MACE and hospitalization for heart failure.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.